VHL Gene
Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.
What the VHL Gene Means
The VHL gene, also known as the Von Hippel-Lindau gene, is a gene that produces a protein important for controlling how cells grow, divide, and function. This protein helps prevent cells from growing too quickly or in an uncontrolled way. Everyone has two copies of the VHL gene, one inherited from each parent.
Sometimes, changes called mutations occur in the VHL gene. These mutations can cause the gene to stop working properly, which may lead to abnormal cell growth. When this happens, it can cause a rare inherited condition called Von Hippel-Lindau (VHL) syndrome.
Why the VHL Gene Matters in Cancer Care
VHL syndrome increases the risk of developing certain tumors, including kidney cancer known as clear cell renal cell cancer (ccRCC), as well as tumors in the brain, spinal cord, eyes, adrenal glands, and pancreas. Because VHL syndrome is inherited, it can run in families, meaning multiple family members may be affected.
Knowing about changes in the VHL gene can help doctors identify people at higher risk for these tumors. This information can guide decisions about screening, monitoring, and treatment to catch tumors early or manage them effectively.
What Patients Might See or Hear About the VHL Gene
If the VHL gene is mentioned in your medical records, test results, or discussions with your healthcare team, it may be related to genetic testing or a diagnosis of VHL syndrome. You might hear about genetic counseling, which is a process where a trained professional helps you understand your family history, the risks of inherited conditions, and whether genetic testing is right for you.
People with a family history of kidney cancer, multiple tumors, or early-onset kidney cancer may be offered genetic testing to check for VHL gene mutations. Testing usually involves a blood or saliva sample.
Where the Term VHL Gene Might Appear
The term VHL gene can appear in genetic test reports, treatment plans, visit notes, or educational materials about hereditary kidney cancer syndromes. It may also come up when discussing clinical trials or targeted therapies related to tumors caused by VHL mutations.
What the VHL Gene Does Not Automatically Mean
Finding a change in the VHL gene does not mean a person definitely has cancer or will develop tumors. It means there is an increased risk. Many people with VHL gene mutations live with careful monitoring and early treatment to manage their health. Also, not all kidney cancers are caused by VHL gene changes; most kidney cancers happen without inherited gene mutations.
Common Questions to Ask Your Care Team
If the VHL gene is part of your care discussion, you might ask: What does this gene change mean for my health? Should my family members be tested? What screening or monitoring should I have? Are there treatments or clinical trials available for tumors linked to VHL? How will this affect my long-term care plan?
Understanding the VHL Gene in Context
The VHL gene is one of several genes linked to hereditary kidney cancer syndromes. It is important to consider it alongside family history, symptoms, and other test results. Genetic counseling can help explain how this gene fits into your overall health picture.
Safety and Next Steps
This information is educational and does not replace medical advice. If you see the term VHL gene in your medical records or hear it from your care team, the best next step is to ask your healthcare provider what it means for your specific situation. They can guide you on genetic counseling, testing, and appropriate follow-up care tailored to your needs.
Sources
Public source information used for this glossary entry includes: